☰

Keith A. Vossel - Publications

Affiliations: 
Gladstone Institute of Neurological Disease, San Francisco, CA, United States 
Area:
neurodegenerative disease
Tree Info Grants Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Prabhu P, Morise H, Kudo K, Beagle A, Mizuiri D, Syed F, Kotegar KA, Findlay A, Miller BL, Kramer JH, Rankin KP, Garcia PA, Kirsch HE, Vossel K, Nagarajan SS, et al. Abnormal gamma phase-amplitude coupling in the parahippocampal cortex is associated with network hyperexcitability in Alzheimer's disease. Brain Communications. 6: fcae121. PMID 38665964 DOI: 10.1093/braincomms/fcae121  0.346
2024 Kudo K, Ranasinghe KG, Morise H, Syed F, Sekihara K, Rankin KP, Miller BL, Kramer JH, Rabinovici GD, Vossel K, Kirsch HE, Nagarajan SS. Neurophysiological trajectories in Alzheimer's disease progression. Elife. 12. PMID 38546337 DOI: 10.7554/eLife.91044  0.403
2024 Verma P, Ranasinghe K, Prasad J, Cai C, Xie X, Lerner H, Mizuiri D, Miller B, Rankin K, Vossel K, Cheung SW, Nagarajan SS, Raj A. Impaired long-range excitatory time scale predicts abnormal neural oscillations and cognitive deficits in Alzheimer's disease. Alzheimer's Research & Therapy. 16: 62. PMID 38504361 DOI: 10.1186/s13195-024-01426-7  0.422
2024 Vicente M, Addo-Osafo K, Vossel K. Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies. Frontiers in Neurology. 15: 1277613. PMID 38390593 DOI: 10.3389/fneur.2024.1277613  0.455
2023 Hickman LB, Stern JM, Silverman DHS, Salamon N, Vossel K. Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology. Frontiers in Neurology. 14: 1241638. PMID 37830092 DOI: 10.3389/fneur.2023.1241638  0.364
2023 Vossel K. Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity. Journal of Alzheimer's Disease : Jad. 94: 1075-1077. PMID 37522212 DOI: 10.3233/JAD-230613  0.376
2023 Kudo K, Ranasinghe KG, Morise H, Syed F, Sekihara K, Rankin KP, Miller BL, Kramer JH, Rabinovici GD, Vossel K, Kirsch HE, Nagarajan SS. Neurophysiological trajectories in Alzheimer's disease progression. Biorxiv : the Preprint Server For Biology. PMID 37293044 DOI: 10.1101/2023.05.18.541379  0.414
2023 Verma P, Ranasinghe K, Prasad J, Cai C, Xie X, Lerner H, Mizuiri D, Miller B, Rankin K, Vossel K, Cheung S, Nagarajan S, Raj A. Spectral graph modeling reveals global slowing of neurophysiological network transmission in Alzheimer's disease. Research Square. PMID 36993350 DOI: 10.21203/rs.3.rs-2579392/v2  0.409
2022 Hwang K, Vaknalli RN, Addo-Osafo K, Vicente M, Vossel K. Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms. Frontiers in Aging Neuroscience. 14: 903973. PMID 35923547 DOI: 10.3389/fnagi.2022.903973  0.349
2022 Ranasinghe K, Verma P, Cai C, Xie X, Kudo K, Gao X, Lerner H, Mizuiri D, Strom A, Iaccarino L, La Joie R, Miller BL, Gorno-Tempini ML, Rankin KP, Jagust WJ, ... Vossel K, et al. Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer's disease. Elife. 11. PMID 35616532 DOI: 10.7554/eLife.77850  0.401
2021 Ranasinghe KG, Kudo K, Hinkley L, Beagle A, Lerner H, Mizuiri D, Findlay A, Miller BL, Kramer JH, Gorno-Tempini ML, Rabinovici GD, Rankin KP, Garcia PA, Kirsch HE, Vossel KA, et al. Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease. Brain : a Journal of Neurology. PMID 34919638 DOI: 10.1093/brain/awab442  0.389
2021 Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, et al. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial. Jama Neurology. PMID 34570177 DOI: 10.1001/jamaneurol.2021.3310  0.618
2021 Ranasinghe KG, Petersen C, Kudo K, Mizuiri D, Rankin KP, Rabinovici GD, Gorno-Tempini ML, Seeley WW, Spina S, Miller BL, Vossel K, Grinberg LT, Nagarajan SS. Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33884753 DOI: 10.1002/alz.12349  0.362
2020 Peters ST, Fahrenkopf A, Choquette JM, Vermilyea SC, Lee MK, Vossel K. Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein. Frontiers in Neurology. 11: 563. PMID 32636798 DOI: 10.3389/Fneur.2020.00563  0.451
2020 Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline. Science Translational Medicine. 12. PMID 32161102 DOI: 10.1126/Scitranslmed.Aaz4069  0.505
2019 Gamache JE, Kemper L, Steuer E, Leinonen-Wright K, Choquette JM, Hlynialuk C, Benzow K, Vossel KA, Xia W, Koob MD, Ashe KH. Developmental pathogenicity of 4-repeat human tau is lost with the P301L mutation in genetically matched tau-transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31685653 DOI: 10.1523/Jneurosci.1256-19.2019  0.411
2019 Ranasinghe KG, Kothare H, Kort N, Hinkley LB, Beagle AJ, Mizuiri D, Honma SM, Lee R, Miller BL, Gorno-Tempini ML, Vossel KA, Houde JF, Nagarajan SS. Neural correlates of abnormal auditory feedback processing during speech production in Alzheimer's disease. Scientific Reports. 9: 5686. PMID 30952883 DOI: 10.1038/S41598-019-41794-X  0.423
2019 La AL, Walsh CM, Neylan TC, Vossel KA, Yaffe K, Krystal AD, Miller BL, Karageorgiou E. Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers. Journal of Alzheimer's Disease : Jad. PMID 30689583 DOI: 10.3233/Jad-181145  0.303
2019 Castro M, Pook KA, Deyle DR, Bower M, Boeve BF, Vossel KA. P4-484: EARLY-ONSET FRONTOTEMPORAL DEMENTIA IN A PATIENT WITH DUPLICATION OF EXON 15 OF THE MATR3 GENE Alzheimer's & Dementia. 15: P1498-P1498. DOI: 10.1016/J.Jalz.2019.08.030  0.335
2019 Karageorgiou E, La A, Krystal A, Walsh C, Neylan T, Vossel KA, Yaffe K, Miller BL. F2-05-04: Slow Wave Sleep Enhancers As A Potential Therapeutic Approach In Delaying Cognitive Decline In Alzheimer'S Disease: The Trazodone Paradigm Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4435  0.37
2018 Lutsey PL, Chen N, Mirabelli MC, Lakshminarayan K, Knopman DS, Vossel KA, Gottesman RF, Mosley TH, Alonso A. Impaired Lung Function, Lung Disease and Risk of Incident Dementia. American Journal of Respiratory and Critical Care Medicine. PMID 30433810 DOI: 10.1164/Rccm.201807-1220Oc  0.334
2017 Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A, Karydas A, Kornak J, Sias AC, Rabinovici GD, Gorno-Tempini ML, Boxer AL, De May M, Rankin KP, Sturm VE, ... ... Vossel KA, et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain : a Journal of Neurology. PMID 29053860 DOI: 10.1093/Brain/Awx254  0.435
2017 Ranasinghe KG, Hinkley LB, Beagle AJ, Mizuiri D, Honma SM, Welch AE, Hubbard I, Mandelli ML, Miller ZA, Garrett C, La A, Boxer AL, Houde JF, Miller BL, Vossel KA, et al. Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants. Brain : a Journal of Neurology. 140: 2737-2751. PMID 28969381 DOI: 10.1093/Brain/Awx217  0.302
2017 Beagle AJ, Darwish SM, Ranasinghe KG, La AL, Karageorgiou E, Vossel KA. Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia. Journal of Alzheimer's Disease : Jad. PMID 28826176 DOI: 10.3233/Jad-170031  0.471
2017 Miyamoto T, Stein L, Thomas R, Djukic B, Taneja P, Knox J, Vossel K, Mucke L. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Molecular Neurodegeneration. 12: 41. PMID 28526038 DOI: 10.1186/S13024-017-0176-X  0.575
2017 Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer's disease: causes and clinical relevance. The Lancet. Neurology. 16: 311-322. PMID 28327340 DOI: 10.1016/S1474-4422(17)30044-3  0.486
2017 Karageorgiou E, Vossel KA. Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28302453 DOI: 10.1016/J.Jalz.2017.02.003  0.406
2017 Ranasinghe KG, Gill JS, Kothare H, Beagle AJ, Mizuiri D, Honma SM, Gorno-Tempini ML, Miller BL, Vossel KA, Nagarajan SS, Houde JF. Abnormal vocal behavior predicts executive and memory deficits in Alzheimer's disease. Neurobiology of Aging. 52: 71-80. PMID 28131013 DOI: 10.1016/J.Neurobiolaging.2016.12.020  0.387
2016 Bertoux M, Sarazin M, Pasquier F, Bottlaender M, de Souza LC, Mioshi E, Hornberger M, Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, You SC, ... ... Vossel KA, et al. Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology. 87: 1523. PMID 27698154 DOI: 10.1212/01.Wnl.0000503343.29930.76  0.326
2016 Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, Darwish SM, Van Berlo V, Barnes DE, Mantle M, Karydas AM, Coppola G, Roberson ED, Miller BL, Garcia PA, et al. Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease. Annals of Neurology. PMID 27696483 DOI: 10.1002/Ana.24794  0.634
2016 Ranasinghe KG, Rankin KP, Pressman PS, Perry DC, Lobach IV, Seeley WW, Coppola G, Karydas AM, Grinberg LT, Shany-Ur T, Lee SE, Rabinovici GD, Rosen HJ, Gorno-Tempini ML, Boxer AL, ... ... Vossel KA, et al. Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration. Jama Neurology. PMID 27429218 DOI: 10.1001/Jamaneurol.2016.2016  0.367
2016 Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26962052 DOI: 10.1093/Brain/Aww027  0.477
2016 Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, Christine You S, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, ... ... Vossel KA, et al. Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology. PMID 26802093 DOI: 10.1212/Wnl.0000000000002373  0.421
2015 Morris M, Sanchez PE, Verret L, Beagle AJ, Guo W, Dubal D, Ranasinghe KG, Koyama A, Ho K, Yu GQ, Vossel KA, Mucke L. Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia. Annals of Clinical and Translational Neurology. 2: 1012-28. PMID 26732627 DOI: 10.1002/Acn3.257  0.67
2015 Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, Ho K, Kim DH, Yu GQ, Mucke L. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β. The Journal of Cell Biology. 209: 419-33. PMID 25963821 DOI: 10.1083/Jcb.201407065  0.609
2015 Vossel KA, Xu J, Fomenko V, Miyamoto T, Suberbielle E, Knox J, Ho K, Kim D, Yu G, Mucke L. Tau reduction prevents Aß-induced axonal transport deficits by blocking activation of GSK3ß The Journal of Experimental Medicine. 212: 2125OIA25. DOI: 10.1084/jem.2125OIA25  0.499
2014 Ranasinghe KG, Hinkley LB, Beagle AJ, Mizuiri D, Dowling AF, Honma SM, Finucane MM, Scherling C, Miller BL, Nagarajan SS, Vossel KA. Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum. Neuroimage. Clinical. 5: 385-95. PMID 25180158 DOI: 10.1016/J.Nicl.2014.07.006  0.468
2013 Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. Jama Neurology. 70: 1158-66. PMID 23835471 DOI: 10.1001/Jamaneurol.2013.136  0.623
2013 Vossel KA, Bien-Ly N, Bernardo A, Rascovsky K, Karydas A, Rabinovici GD, Sidhu M, Huang EJ, Miller BL, Huang Y, Seeley WW. ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease. Neurocase. 19: 295-301. PMID 22512241 DOI: 10.1080/13554794.2012.667124  0.402
2012 Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu GQ, Palop JJ, Mucke L. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proceedings of the National Academy of Sciences of the United States of America. 109: E2895-903. PMID 22869752 DOI: 10.1073/Pnas.1121081109  0.719
2012 Vossel KA, Beagle A, Hegde M, Mantle M, Kirsch H, Garcia P, Honma S, Findlay A, Rabinovici G, Jagust W, Nagarajan S, Miller B, Roberson E, Mucke L. P2-377: Subclinical epileptiform activity in Alzheimer's disease Alzheimer's & Dementia. 8: P395-P396. DOI: 10.1016/J.Jalz.2012.05.1087  0.612
2011 Morris M, Maeda S, Vossel K, Mucke L. The many faces of tau. Neuron. 70: 410-26. PMID 21555069 DOI: 10.1016/J.Neuron.2011.04.009  0.564
2011 Sanchez P, Vossel KA, Ho K, Kim DH, Yu G, Verret L, Palop JJ, Mucke L. P3-463: Reducing epileptiform activity by levetiracetam rescues synaptic and cognitive functions in a mouse model of Alzheimer's disease Alzheimer's & Dementia. 7: S664-S664. DOI: 10.1016/J.Jalz.2011.05.1907  0.701
2010 Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L. Tau reduction prevents Abeta-induced defects in axonal transport. Science (New York, N.Y.). 330: 198. PMID 20829454 DOI: 10.1126/Science.1194653  0.604
2009 Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America. 106: 2018-22. PMID 19164761 DOI: 10.1073/Pnas.0812697106  0.478
2008 Vossel KA, Miller BL. New approaches to the treatment of frontotemporal lobar degeneration. Current Opinion in Neurology. 21: 708-16. PMID 18989117 DOI: 10.1097/Wco.0B013E328318444D  0.397
2008 Vossel KA, Agosta F, Karydas AM, Boxer AL, Bonasera SJ, Miller BL, Gorno-Tempini ML. P3-282: Apolipoprotein E4 allele and grey matter atrophy in frontotemporal dementia and Alzheimer's disease: A disease-specific regional effect Alzheimer's & Dementia. 4: T605-T605. DOI: 10.1016/J.Jalz.2008.05.1850  0.439
2006 Ranasinghe KG, Cha J, Hinkley LB, Beagle AJ, Mizuiri D, Honma S, Bourakova V, Jagust WJ, Miller BL, Rabinovici GD, Nagarajan SS, Vossel KA. O1-01-05: DISTINCT NEURAL OSCILLATION ABNORMALITIES ASSOCIATED WITH AMYLOID-BETA AND TAU IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P213-P214. DOI: 10.1016/J.Jalz.2018.06.2334  0.405
Show low-probability matches.